Vik Kashyap
About Vik Kashyap
Vik Kashyap is the Founder and CEO of Toi Labs, where he has developed a new treatment for inflammatory bowel disease. He has a background in both Japan and Silicon Valley, and his academic credentials include an honors degree from Harvard University.
Work at Toi Labs
Vik Kashyap serves as the Founder and CEO of Toi Labs, a position he has held since 2018. Under his leadership, the company focuses on innovative solutions in the healthcare sector, particularly in the treatment of inflammatory bowel disease (IBD). His role involves overseeing the strategic direction and operational management of the organization, contributing to advancements in medical technology and patient care.
Education and Expertise
Vik Kashyap studied at Harvard University, where he achieved an AB with honors. His educational background provides a strong foundation for his work in the medical and technology fields. This academic experience, combined with his professional endeavors, equips him with the expertise necessary to lead initiatives aimed at addressing complex health issues.
Background
Vik Kashyap has a diverse professional background that includes significant experience in both Japan and Silicon Valley. Prior to founding Toi Labs, he worked at Battery Ventures as a Senior Associate from 1998 to 2002. His international experience and exposure to various markets contribute to his understanding of global health challenges and innovative solutions.
Achievements
Vik Kashyap has made notable contributions to the field of medical research. He developed a new treatment for inflammatory bowel disease (IBD) and co-authored a paper published in Science Translational Medicine, which has been cited over 250 times. Additionally, his work has been featured in two books, 'An Epidemic of Absence' and 'Pipe Dreams', highlighting the impact of his research and innovations.